Seuraa
Maria João Pereira
Maria João Pereira
Vahvistettu sähköpostiosoite verkkotunnuksessa medsci.uu.se
Nimike
Viittaukset
Viittaukset
Vuosi
Emerging role of SGLT-2 inhibitors for the treatment of obesity
MJ Pereira, JW Eriksson
Drugs 79 (3), 219-230, 2019
2432019
mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes
MJ Pereira, J Palming, M Rizell, M Aureliano, E Carvalho, MK Svensson, ...
Molecular and cellular endocrinology 355 (1), 96-105, 2012
1122012
FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance
MJ Pereira, J Palming, MK Svensson, M Rizell, J Dalenbäck, M Hammar, ...
Metabolism 63 (9), 1198-1208, 2014
1052014
Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: a 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in …
P Lundkvist, CD Sjöström, S Amini, MJ Pereira, E Johnsson, JW Eriksson
Diabetes, Obesity and Metabolism 19 (1), 49-60, 2017
1012017
Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes
MJ Pereira, E Carvalho, JW Eriksson, DC Crans, M Aureliano
Journal of Inorganic Biochemistry 103 (12), 1687-1692, 2009
1012009
The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in …
MJ Pereira, J Palming, M Rizell, M Aureliano, E Carvalho, MK Svensson, ...
Molecular and cellular endocrinology 365 (2), 260-269, 2013
992013
FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes
CO Sidibeh, MJ Pereira, XM Abalo, G J Boersma, S Skrtic, P Lundkvist, ...
Endocrine 62, 116-128, 2018
772018
Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of …
MJ Pereira, J Palming, M Rizell, M Aureliano, E Carvalho, MK Svensson, ...
The Journal of Clinical Endocrinology & Metabolism 99 (10), E1885-E1894, 2014
772014
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: S ustained reductions in body weight, glycaemia and blood pressure over 1 year
P Lundkvist, MJ Pereira, P Katsogiannos, CD Sjöström, E Johnsson, ...
Diabetes, Obesity and Metabolism 19 (9), 1276-1288, 2017
702017
Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important …
MJ Pereira, S Skrtic, P Katsogiannos, N Abrahamsson, CO Sidibeh, ...
Metabolism 65 (12), 1768-1780, 2016
662016
Altered glucose uptake in muscle, visceral adipose tissue, and brain predict whole-body insulin resistance and may contribute to the development of type 2 diabetes: a combined …
GJ Boersma, E Johansson, MJ Pereira, K Heurling, S Skrtic, J Lau, ...
Hormone and metabolic research 50 (08), 627-639, 2018
632018
Characterization of brown adipose tissue in the human perirenal depot
PA Svensson, K Lindberg, JM Hoffmann, M Taube, MJ Pereira, ...
Obesity 22 (8), 1830-1837, 2014
562014
Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance
CO Sidibeh, MJ Pereira, J Lau Börjesson, PG Kamble, S Skrtic, ...
Endocrine 55, 839-852, 2017
502017
The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate
PA Svensson, M Olsson, JC Andersson-Assarsson, M Taube, MJ Pereira, ...
Biochemical and biophysical research communications 433 (4), 563-566, 2013
482013
Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model
A Fuhrmann, PC Lopes, J Sereno, J Pedro, DO Espinoza, MJ Pereira, ...
Biochemical pharmacology 88 (2), 216-228, 2014
462014
Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes
MJ Pereira, K Thombare, A Sarsenbayeva, PG Kamble, K Almby, ...
Molecular and cellular endocrinology 503, 110696, 2020
432020
Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue
PG Kamble, MJ Pereira, CO Sidibeh, S Amini, M Sundbom, JL Börjesson, ...
Molecular and cellular endocrinology 427, 124-132, 2016
432016
Intra-and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes
K Diamanti, M Cavalli, G Pan, MJ Pereira, C Kumar, S Skrtic, M Grabherr, ...
Scientific reports 9 (1), 9653, 2019
402019
Glucagon levels during short-term SGLT2 inhibition are largely regulated by glucose changes in patients with type 2 diabetes
P Lundkvist, MJ Pereira, PG Kamble, P Katsogiannos, AM Langkilde, ...
The Journal of Clinical Endocrinology & Metabolism 104 (1), 193-201, 2019
402019
Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism
PG Kamble, S Hetty, M Vranic, K Almby, C Castillejo-López, XM Abalo, ...
Scientific Reports 10 (1), 10565, 2020
332020
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20